CHI Advisors as of Dec. 31, 2021
Portfolio Holdings for CHI Advisors
CHI Advisors holds 20 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 23.0 | $69M | 1.8M | 39.54 | |
| Repare Therapeutics Ord (RPTX) | 15.5 | $47M | 2.2M | 21.09 | |
| Cullinan Oncology (CGEM) | 12.7 | $38M | 2.5M | 15.43 | |
| Pliant Therapeutics (PLRX) | 11.5 | $35M | 2.6M | 13.50 | |
| Larimar Therapeutics (LRMR) | 5.4 | $16M | 1.5M | 10.79 | |
| Vectivbio Hldg Ord Shs | 4.4 | $13M | 2.7M | 4.91 | |
| Omega Therapeutics Common Stock (OMGAQ) | 4.0 | $12M | 1.1M | 11.33 | |
| Oncorus | 3.7 | $11M | 2.1M | 5.27 | |
| Ikena Oncology (IKNA) | 3.4 | $10M | 815k | 12.54 | |
| Compass Therapeutics (CMPX) | 3.2 | $9.6M | 3.0M | 3.17 | |
| Orchard Therapeutics Ads | 2.8 | $8.5M | 6.4M | 1.32 | |
| Akouos | 2.4 | $7.1M | 836k | 8.50 | |
| Inozyme Pharma (INZY) | 2.0 | $6.1M | 892k | 6.82 | |
| Kezar Life Sciences | 1.5 | $4.6M | 272k | 16.72 | |
| Precision Biosciences Ord | 1.5 | $4.5M | 607k | 7.40 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 1.2 | $3.7M | 1.9M | 1.98 | |
| G1 Therapeutics | 0.8 | $2.3M | 230k | 10.21 | |
| Ovid Therapeutics (OVID) | 0.4 | $1.3M | 400k | 3.21 | |
| Keros Therapeutics (KROS) | 0.3 | $1.0M | 18k | 58.51 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $964k | 400k | 2.41 |
